Muscle tissue — efficacy & protocols
Ultra-high-purity exosomes for muscle recovery — acute injury, chronic strain and atrophy, with onset timelines and the underlying targeting principle.
Containing 100 billion ultra-high-purity, full-signal-spectrum exosomes, focused on rebuilding the body’s overall homeostasis. Using high-purity exosomes as a “native signal matrix”, it precisely delivers thousands of regulatory factors (miRNA, active proteins) through the systemic circulation to trigger the body’s own anti-inflammatory and repair mechanisms. Through multi-pathway synergy, it deeply intervenes across the ten core hallmarks of aging research — Inflammaging, Tissue Repair, Antioxidant Focus, Cellular Communication, Genomic Integrity, Metabolic Balance, Proteostasis, Senescence Delay, Telomere Maintenance — to achieve systemic homeostatic restoration.
Acute Muscle Injury Repair
Stimulate muscle cell regeneration, reduce inflammation, swelling and pain, speed up muscle recovery after injury or surgery.
swelling and pain significantly relieved, range of motion increased
muscle fibers repaired, muscle strength recovered by more than 70%
muscle structure restored, elasticity and strength returned to normal
How to use: Prioritize local application/injection; avoid weight-bearing training in the early stages of injury.
Targeting principle & mechanism
Core functional proteins: IGF-1, bFGF, VEGF, TGF-β3, IL-10, HSP70, SOD, MyoD, myoglobin, fibronectin
Targets: Skeletal-muscle satellite cells, damaged fibres, sarcolemma cells, injury-site macrophages, vascular endothelium
Targeting logic: After acute strain or contusion, injured fibres release CXCL12 and TNF-α and the sarcolemma over-expresses integrin receptors; exosomes home via CXCR4 to the injured area, anchoring damaged fibres and satellite cells while sparing healthy muscle.
- IGF-1 and MyoD activate satellite-cell proliferation and differentiation to form new fibres, rapidly repairing torn fibres and restoring contraction.
- bFGF and VEGF regenerate microvasculature at the injury site, improving blood and oxygen supply and clearing metabolic waste.
- IL-10 and TGF-β3 inhibit NF-κB and shift M1→M2 macrophages, quickly easing swelling and pain and limiting damage to healthy fibres.
- HSP70 and SOD clear oxidative radicals, reducing myocyte apoptosis and post-injury fibrosis risk.
- Fibronectin rebuilds the muscle matrix scaffold and repairs the sarcolemma, restoring structural integrity.
Chronic Strain & Myofasciitis Repair
Improve muscle microcirculation, repair minor lesions, ease soreness, stiffness and nodules.
soreness and stiffness reduced, range of motion expanded
strain nodules softened, muscles are less prone to fatigue
chronic inflammation subsided, muscle toughness enhanced
How to use: Topical application/infusion; combined with stretching and myofascial release to correct poor posture.
Targeting principle & mechanism
Core functional proteins: IL-10, TGF-β3, HSP70, SOD, bFGF, PDGF, NGF antagonists, collagenase inhibitors, antimicrobial peptides
Targets: Skeletal-muscle fibroblasts, myofascial cells, local immune cells, sensory nerve endings, damaged fibres
Targeting logic: Chronic strain and myofasciitis carry persistent sterile inflammation, fascial adhesion and micro-injury, continuously releasing CXCL12 and pro-inflammatory factors; exosomes enrich the strained area and target fascia and damaged fibres.
- IL-10 and TGF-β3 suppress chronic sterile inflammation and down-regulate TNF-α and IL-6, easing soreness and stiffness and improving fascial adhesion.
- NGF antagonists dampen over-sensitised sensory nerve endings, relieving the persistent pain of chronic strain.
- bFGF and PDGF repair damaged fibres and fascial cells, improving elasticity and reducing recurrence.
- HSP70 and SOD clear long-term oxidative damage, reducing apoptosis and chronic fatigue.
- Collagenase inhibitors rebalance collagen to reduce abnormal fascial thickening and restore gliding; antimicrobial peptides prevent secondary infection.
Muscle Atrophy & Strength Decline Improvement
Suppress muscle protein breakdown, boost protein synthesis, improve age- and illness-related muscle weakness and atrophy.
muscle firmness and limb strength improved
muscle mass increased, muscle fibers become thicker
muscle atrophy significantly improved, physical fitness and endurance enhanced
How to use: Combined with a high-protein diet and light resistance training; used regularly throughout the course of treatment.
Targeting principle & mechanism
Core functional proteins: IGF-1, bFGF, MyoD, MGF, VEGF, TGF-β3, IL-10, SOD, MMP inhibitors, myostatin antagonists
Targets: Satellite cells, muscle fibres, myonuclei, muscle vascular endothelium, interstitial fibroblasts
Targeting logic: In atrophic, weakening areas the fibres thin and satellite-cell function is suppressed, with ongoing oxidative-stress signalling; exosomes target the atrophic region, acting on satellite cells and fibres to promote hypertrophy and recovery.
- Myostatin antagonists block the myostatin pathway, releasing the brake on satellite cells to drive fibre hypertrophy and number, reversing atrophy.
- IGF-1, MGF and MyoD activate satellite-cell proliferation and differentiation, boosting protein synthesis and fibre cross-section and strength.
- VEGF improves muscle microcirculation, raising oxygen and nutrient supply for better endurance.
- TGF-β3 and MMP inhibitors inhibit muscle fibrosis and abnormal collagen build-up, preserving normal structure.
- IL-10 and SOD clear chronic inflammation and oxidative radicals, reducing apoptosis and slowing age-related decline.
How exosomes target muscle tissue
Core functional proteins: CD9 / CD63 / CD81 tetraspanins, integrins, ICAM adhesion proteins, chemokine receptor CXCR4
Targets: Damaged / atrophic muscle tissue and their target cells (satellite cells, muscle fibres)
- Targeted recognition: via CXCR4 and integrins the exosome membrane reads the lesion-signal gradient and homes to damaged muscle, actively grabbing the injury while barely retaining in healthy tissue.
- Delivery: the 30–150 nm nanoscale travels via the circulation and local tissue; with its phospholipid bilayer it enters cells intact via both passive penetration and active endocytosis, without being broken down.
- Intracellular release: once inside the cell the membrane fuses and ruptures, releasing functional proteins that directly regulate cell genes and signalling pathways — repairing fibres and reversing atrophy from the root.